1 completed, 1 recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Hyperkinesis: new trials by email Literature Review of Hyperkinesis trials Research Report on Hyperkinesis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tianasen (ASO-GNAO1) for GNAO1-Encephalopathy With Epilepsy and Movement Disorders. Antisense oligonucleotide treatment (ASO) - GNAO1, Epilepsy | Phase 1 / Phase 2 | Recruiting | Pirogov Russian National Research Medical University | 5 | 2025-09-09 | 2026-01-23 |
| Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial Tipepidine Hibenzate, Placebo - Attention Deficit Disorder With Hyperactivity Disease, Hyperkinesis | Phase 1 / Phase 2 | Completed | Chiba University | 21 | 2015-06-11 | 2019-03-19 |
Attention Deficit and Disruptive Behavior Disorders (1) · Epilepsy (1)
Dyskinesias (2) · Nervous System Diseases (2) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Mental Disorders (1) · Neurodevelopmental Disorders (1)
tipepidine (1)
Chiba University (1) · Pirogov Russian National Research Medical University (1)
Japan (1) · Russia (1)